{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:02:31Z","timestamp":1774450951978,"version":"3.50.1"},"reference-count":40,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Grant-in-Aid for Scientific Research (B)","award":["26293131"],"award-info":[{"award-number":["26293131"]}]},{"name":"Grant-in-Aid for Scientific Research on Priority Areas","award":["21026015"],"award-info":[{"award-number":["21026015"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Med Sci Sports"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>We previously demonstrated that nerve growth factor (<jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>) and glial cell line\u2010derived neurotrophic factor (<jats:styled-content style=\"fixed-case\">GDNF<\/jats:styled-content>) were upregulated after lengthening contractions (<jats:styled-content style=\"fixed-case\">LC<\/jats:styled-content>) in exercised muscle through B2 bradykinin receptor activation and cyclooxygenase (<jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>)\u20102 upregulation, respectively, and that these trophic factors sensitized nociceptors resulting in mechanical hyperalgesia (delayed\u2010onset muscle soreness,<jats:styled-content style=\"fixed-case\">DOMS<\/jats:styled-content>). Here, we examined the prostaglandin receptor subtype involved in<jats:styled-content style=\"fixed-case\">DOMS<\/jats:styled-content>. The mechanical withdrawal threshold of the exercised muscle was measured before and after<jats:styled-content style=\"fixed-case\">LC<\/jats:styled-content>in rats administered prostaglandin E<jats:sub>2<\/jats:sub>receptor (<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>) antagonists before<jats:styled-content style=\"fixed-case\">LC<\/jats:styled-content>, or in wild\u2010type (<jats:styled-content style=\"fixed-case\">WT<\/jats:styled-content>),<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>2 knockout (<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>2<jats:sup>\u2212\/\u2212<\/jats:sup>), and<jats:styled-content style=\"fixed-case\">IP<\/jats:styled-content>knockout (<jats:styled-content style=\"fixed-case\">IP<\/jats:styled-content><jats:sup>\u2212\/\u2212<\/jats:sup>) mice. The change in expression of<jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">GDNF<\/jats:styled-content>, or<jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\u20102<jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content>was examined using real\u2010time<jats:styled-content style=\"fixed-case\">RT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>in the muscle in<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>2<jats:sup>\u2212\/\u2212<\/jats:sup>and<jats:styled-content style=\"fixed-case\">WT<\/jats:styled-content>mice. None of the antagonists to<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>1,<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>3, and<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>4 receptors (<jats:styled-content style=\"fixed-case\">ONO<\/jats:styled-content>\u20108713,<jats:styled-content style=\"fixed-case\">ONO<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">AE<\/jats:styled-content>5\u2010599, and<jats:styled-content style=\"fixed-case\">ONO<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">AE<\/jats:styled-content>3\u2010208, respectively) induced a significant difference in<jats:styled-content style=\"fixed-case\">DOMS<\/jats:styled-content>compared with controls in rats.<jats:styled-content style=\"fixed-case\">WT<\/jats:styled-content>and<jats:styled-content style=\"fixed-case\">IP<\/jats:styled-content><jats:sup>\u2212\/\u2212<\/jats:sup>mice developed mechanical hyperalgesia after<jats:styled-content style=\"fixed-case\">LC<\/jats:styled-content>, but<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>2<jats:sup>\u2212\/\u2212<\/jats:sup>mice did not. Upregulation of<jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">GDNF<\/jats:styled-content>, and<jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\u20102<jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content>was observed after<jats:styled-content style=\"fixed-case\">LC<\/jats:styled-content>in<jats:styled-content style=\"fixed-case\">WT<\/jats:styled-content>mice but not in<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>2<jats:sup>\u2212\/\u2212<\/jats:sup>mice. Injecting an<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>2 agonist (<jats:styled-content style=\"fixed-case\">ONO<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">AE<\/jats:styled-content>1\u2010259\u201001) into the mouse muscle increased expression of<jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\u20102<jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content>. These results suggest that<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>2 contributes to generating mechanical hyperalgesia through positive feedback upregulation of<jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\u20102 expression in muscle after LC.<\/jats:p>","DOI":"10.1111\/sms.12954","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T15:52:41Z","timestamp":1501516361000},"page":"826-833","source":"Crossref","is-referenced-by-count":7,"title":["<scp>EP<\/scp>2 receptor plays pivotal roles in generating mechanical hyperalgesia after lengthening contractions"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4746-8845","authenticated-orcid":false,"given":"H.","family":"Ota","sequence":"first","affiliation":[{"name":"Department of Neuroscience II Graduate School of Medicine Nagoya University Nagoya Japan"},{"name":"Department of Judo Therapy Faculty of Medical Technology Teikyo University Utsunomiya Japan"},{"name":"Department of Physical Therapy College of Life and Health Sciences Chubu University Kasugai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Katanosaka","sequence":"additional","affiliation":[{"name":"Department of Neuroscience II Graduate School of Medicine Nagoya University Nagoya Japan"},{"name":"Department of Biomedical Sciences College of Life and Health Sciences Chubu University Kasugai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Murase","sequence":"additional","affiliation":[{"name":"Department of Neuroscience II Graduate School of Medicine Nagoya University Nagoya Japan"},{"name":"Department of Physical Therapy College of Life and Health Sciences Chubu University Kasugai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Furuyashiki","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Graduate School of Medicine Kyoto University Kyoto Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Narumiya","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Graduate School of Medicine Kyoto University Kyoto Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Mizumura","sequence":"additional","affiliation":[{"name":"Department of Neuroscience II Graduate School of Medicine Nagoya University Nagoya Japan"},{"name":"Department of Physical Therapy College of Life and Health Sciences Chubu University Kasugai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1249\/00005768-198412000-00002"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/08990220600856255"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.4085\/1062-6050-50.11.05"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-200333020-00005"},{"key":"e_1_2_8_6_1","first-page":"72","article-title":"Eccentric exercise\u2010induced delayed\u2010onset muscle soreness and changes in markers of muscle damage and inflammation","volume":"19","author":"Kanda K","year":"2013","journal-title":"Exerc Immunol Rev"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000000980"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1249\/00005768-199105000-00006"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065751"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2004.079483"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.08.013"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.909"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3803-09.2010"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/sms.12013"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1532-2149.2013.00411.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2012.249235"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(95)90173-6"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.290.5489.124"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2011.04.003"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(02)00958-2"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.2506"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00904.2008"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1991.71.5.1837"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000320"},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-6997(25)06784-5","article-title":"International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes","volume":"46","author":"Coleman RA","year":"1994","journal-title":"Pharmacol Rev"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.661"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1999.79.4.1193"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-011-9317-9"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/2040-7378-2-12"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2009.05.009"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e31820c5353"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e3182685ba1"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23618"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-1-3"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(92)90395-I"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0901-1048"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01358.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.192"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgm011"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20111052"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-011-1999-8"}],"container-title":["Scandinavian Journal of Medicine &amp; Science in Sports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fsms.12954","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/sms.12954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:09:54Z","timestamp":1750792194000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/sms.12954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1111\/sms.12954"],"URL":"https:\/\/doi.org\/10.1111\/sms.12954","archive":["Portico"],"relation":{},"ISSN":["0905-7188","1600-0838"],"issn-type":[{"value":"0905-7188","type":"print"},{"value":"1600-0838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]}}}